Search results
1 mar 2011 · The treatment of both nonerosive and erosive IMPA involves immunosuppressive, immunomodulating, and disease-modifying drugs. In dogs with nonerosive IMPA, the prognosis and response to treatment vary according to cause but is often guarded to good, with many patients responding to single agent or combination drug therapy.
25 lis 2013 · Recommendations were developed based on comprehensive review of relevant literature on immunosuppressive therapy of glomerular disease in dogs and humans, contemporary expert opinion, and anecdotal experience in dogs with glomerular disease treated with immunosuppression.
Understand the peri-operative management, staging, and surgical oncology principles for cutaneous MCT in dogs and cats, and the indications for adjunctive radiation therapy or chemotherapy in conjunction with surgery. Understand treatment options for non-resectable MCTs.
5 kwi 2024 · As treatment recommendations and prognostic factors for MCTs continually change, this article aims to demystify the clinical approach to MCTs by reviewing indications for use of the MCT prognostic panel, the clinical relevance of regional lymph node metastasis, and various local and systemic therapies.
Blood smear in a dog with immune-mediated haemolytic anaemia. Note the anisocytosis (variable size of red blood cells) and polychromasia (presence of polychromatophils: immature red blood cells that are larger and more basophilic; green arrows).
1 gru 2008 · Article. A careful diagnostic process will help you determine whether your veterinary patients will require long-term immunosuppressive therapy. Autoimmune hemolytic anemia, or immune-mediated hemolytic anemia (IMHA), is a complex disease in which hemolysis occurs because of antierythrocyte antibody production.
17 wrz 2018 · Chronic inflammatory enteropathies (CIE) in dogs are a group of disorders that are characterized by chronic persistent or recurrent signs of gastrointestinal disease and histologic evidence of mucosal inflammation. These CIEs are classified as either food‐responsive, antibiotic‐responsive, or immunosuppressant‐responsive enteropathy.
